These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 31470260

  • 21. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.
    Varjú P, Farkas N, Hegyi P, Garami A, Szabó I, Illés A, Solymár M, Vincze Á, Balaskó M, Pár G, Bajor J, Szűcs Á, Huszár O, Pécsi D, Czimmer J.
    PLoS One; 2017; 12(8):e0182942. PubMed ID: 28806407
    [Abstract] [Full Text] [Related]

  • 22. Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial.
    Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, Whelan K.
    J Crohns Colitis; 2017 Dec 04; 11(12):1420-1429. PubMed ID: 28525543
    [Abstract] [Full Text] [Related]

  • 23. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.
    Ankersen DV, Weimers P, Bennedsen M, Haaber AB, Fjordside EL, Beber ME, Lieven C, Saboori S, Vad N, Rannem T, Marker D, Paridaens K, Frahm S, Jensen L, Rosager Hansen M, Burisch J, Munkholm P.
    J Med Internet Res; 2021 Dec 14; 23(12):e30291. PubMed ID: 34904950
    [Abstract] [Full Text] [Related]

  • 24. Low FODMAP Diet Is Not Effective in Children with Functional Abdominal Pain: A Randomized Controlled Trial.
    Boradyn KM, Przybyłowicz KE, Jarocka-Cyrta E.
    Ann Nutr Metab; 2020 Dec 14; 76(5):334-344. PubMed ID: 33075788
    [Abstract] [Full Text] [Related]

  • 25. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Schumann D, Klose P, Lauche R, Dobos G, Langhorst J, Cramer H.
    Nutrition; 2018 Jan 14; 45():24-31. PubMed ID: 29129233
    [Abstract] [Full Text] [Related]

  • 26. Case Report: Initial Successful Treatment of Migraine and Irritable Bowel Syndrome With a Low-FODMAP Diet.
    Bonakdar RA, Sweeney MM, Garvey C, White AA, VanNoord MU.
    J Am Nutr Assoc; 2024 Jan 14; 43(4):339-344. PubMed ID: 38108544
    [Abstract] [Full Text] [Related]

  • 27. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.
    Inflamm Bowel Dis; 2012 Dec 14; 18(12):2218-24. PubMed ID: 22344983
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet.
    Valdez-Palomares F, Nambo-Venegas R, Uribe-García J, Mendoza-Vargas A, Granados-Portillo O, Meraz-Cruz N, Palacios-González B.
    Food Funct; 2021 Apr 07; 12(7):3206-3218. PubMed ID: 33877245
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N.
    Dan Med J; 2015 Dec 07; 62(12):B5168. PubMed ID: 26621403
    [Abstract] [Full Text] [Related]

  • 34. Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic Perspective.
    Orlando A, Tutino V, Notarnicola M, Riezzo G, Linsalata M, Clemente C, Prospero L, Martulli M, D'Attoma B, De Nunzio V, Russo F.
    Nutrients; 2020 Jun 02; 12(6):. PubMed ID: 32498383
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B.
    World J Gastroenterol; 2017 Dec 14; 23(46):8235-8247. PubMed ID: 29290660
    [Abstract] [Full Text] [Related]

  • 36. A Novel Mobile App (Heali) for Disease Treatment in Participants With Irritable Bowel Syndrome: Randomized Controlled Pilot Trial.
    Rafferty AJ, Hall R, Johnston CS.
    J Med Internet Res; 2021 Mar 02; 23(3):e24134. PubMed ID: 33650977
    [Abstract] [Full Text] [Related]

  • 37. Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research.
    Mitchell H, Porter J, Gibson PR, Barrett J, Garg M.
    Aliment Pharmacol Ther; 2019 Jan 02; 49(2):124-139. PubMed ID: 30589971
    [Abstract] [Full Text] [Related]

  • 38. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Puolanne AM, Kolho KL, Alfthan H, Ristimäki A, Mustonen H, Färkkilä M.
    Dig Dis Sci; 2017 Nov 02; 62(11):3123-3130. PubMed ID: 28948412
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
    Ricanek P, Brackmann S, Perminow G, Lyckander LG, Sponheim J, Holme O, Høie O, Rydning A, Vatn MH, IBSEN II Study Group.
    Scand J Gastroenterol; 2011 Sep 02; 46(9):1081-91. PubMed ID: 21619483
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.